Skip to Content Skip to Search
Maya Martinez-Davis
Maya Martinez-Davis

President US Pharmaceuticals

A career in GSK Renal

After years of limited innovation for new treatments that can benefit patients, we have the potential to make a meaningful impact in the lives of those with renal disease. Across GSK, we have the ambition to positively impact the health of 2.5 billion people worldwide over the next 10 years. Every person we help is someone’s parent, child, sibling or friend. Whether you work in Renal or another one of our key therapy areas, you play a critical role in delivering on this ambition.

We are proud to be expanding our team working on Chronic Kidney Disease across North America and Europe and we are seeking experienced and passionate professionals to join our exciting pursuit.

Why is our work in Chronic Kidney Disease important?

Approximately 1 in 10 patients worldwide are affected by chronic kidney disease (CKD), many of whom experience the complication of anaemia which currently leaves them with symptoms that can dramatically reduce quality of life and increase risk of cardiovascular disease, hospitalisation and mortality. At GSK, we are following the science of anaemia to better understand how to help these patients, who are often undiagnosed and undertreated. 

What is anaemia?

Find out more about the consequences of anaemia and why we are developing solutions for patients with anaemia of Chronic Kidney Disease.

Dry lab human genetics group

Job Opportunities

Join us to help improve the lives of patients around the world. We offer global career opportunities across all areas of drug development and commercialisation.

Renal Professionals 

If you are an expert in one of the fields below, we have a role for you. Our vacancies regularly include opportunities for:

Commercial Leadership Scientific Leadership
Sales & Marketing  Medical Affairs 
Insights & Analytics Physicians
Health Economics & Outcomes Research Clinical Development
Quality Drug Development
Supply Chain Regulatory Affairs

Why GSK?

At GSK, we have already delivered unprecedented change over the past four years, improving R&D, becoming a leader in Consumer Healthcare, strengthening our leadership, and transforming our commercial execution. Now, we’re making the most significant changes we’ve made to our business in over 20 years. We’re on track to separate and create two new companies in 2022: new GSK with a leading portfolio of vaccines and speciality medicines as well as R&D based on immune system and genetics science; and a new world-leading consumer healthcare company of loved and trusted brands.

With new ambition comes new purpose. For new GSK, this is to unite science, talent, and technology to get ahead of disease together – all with the clear ambition of delivering human health impact; stronger and more sustainable shareholder returns; and as a new GSK where outstanding people thrive.

Getting ahead means preventing disease as well as treating it. How we do all this is through our people and our culture. A culture that is ambitious for patients – so we deliver what matters better and faster; accountable for impact – with clear ownership of goals and support to succeed; and where we do the right thing. So, if you’re ready to improve the lives of billions, join us at this exciting moment in our journey. Join our challenge to get Ahead Together.